Related Experiment Video
Updated: May 17, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cell-based therapy for ischemic heart disease
Lien-Cheng Hsiao1, Carolyn Carr, Kuan-Cheng Chang
1Cardiac Metabolism Research Group, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. lienchenghsiao@gmail.com
Insights
Stem cell therapy offers a promising new avenue for treating ischemic heart disease (IHD) and chronic heart failure (HF). Research explores various stem cell types and cardiac tissue engineering for cardiac repair and regeneration.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Ischemic heart disease (IHD) remains a leading cause of death globally, with chronic heart failure (HF) post-acute myocardial infarction (AMI) posing significant challenges.
- Current treatments for end-stage HF, like heart transplantation, are limited by donor organ scarcity and the need for lifelong immunosuppression.
- Stem cell-based cardiac therapy has emerged as a promising regenerative approach for IHD over the past decade.
Purpose of the Study:
- To review the characteristics of various stem cell types applicable to cardiac repair.
- To discuss stem cell-based therapeutic strategies for treating IHD.
- To explore cardiac tissue engineering as an alternative to cell transplantation for improving cell retention and survival.
Main Methods:
- Review of current literature on stem cell types (bone marrow cells, cardiac stem cells, induced pluripotent stem cells) for cardiac regeneration.
- Analysis of stem cell-based therapy approaches, including direct cell transplantation and cardiac tissue engineering (CTE).
- Discussion of the potential benefits and challenges associated with different stem cell sources and therapeutic modalities.
Main Results:
- Multiple stem cell types, including bone marrow cells (BMCs), cardiac stem cells (CSCs), and induced pluripotent stem cells (iPSCs), show potential for cardiac repair.
- Stem cell-based therapies, encompassing cell transplantation and cardiac tissue engineering (CTE), are being investigated to address limitations of current HF treatments.
- CTE presents a potential solution to improve the engraftment and survival rates of transplanted cells in cardiac repair.
Conclusions:
- Stem cell-based therapy represents a significant advancement in the potential treatment of ischemic heart disease and chronic heart failure.
- Further research into stem cell characteristics and therapeutic strategies, including CTE, is crucial for clinical translation.
- Developing effective stem cell therapies could offer a viable alternative to heart transplantation for patients with end-stage heart failure.
Abstract:
Despite great advances in therapy over the past decades, ischemic heart disease (IHD) remains the leading cause of death worldwide because the decrease in mortality after acute myocardial infarction (AMI) leads to a longer life span in patients with chronic postinfarct heart failure (HF). There are no existing medical treatments that can cure chronic HF and the only currently available therapeutic option for end-stage HF is heart transplantation. However, transplantation is limited by the shortage of donor organs and patients require lifelong immunosuppression. In the past 10 years, stem cell-based cardiac therapy has been proposed as a promising approach for the treatment of IHD. There is a variety of potential stem cell types for cardiac repair and regeneration, including bone marrow cells (BMCs), resident cardiac stem cells (CSCs) and induced pluripotent stem cells (iPSCs). Stem cell-based therapy may comprise cell transplantation or cardiac tissue engineering (CTE), which might be an attractive alternative to solve the problems of low retention and poor survival of transplanted cells. This review focuses on the characteristics of stem cells from various sources and discusses the strategies of stem cell-based therapy for the treatment of IHD.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

